Newfield Exploration Co. (NFX) Financials Nov 20, 2014,
Newfield Exploration Co. (NFX) Financials Nov 20, 2014, 6:07 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Newfield Exploration Co.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 1.34B 1.88B 2.47B 2.57B 1.79B
Cost of Goods Sold (COGS) incl. D&A 909M 1.1B 1.55B 1.81B 1.08B
COGS excluding D&A 322M 452M 783M 858M 151M
Depreciation & Amortization Expense 587M 644M 767M 955M 930M
Depreciation 587M 644M 767M 955M 930M
Amortization of Intangibles 0 0 0 0 0
Gross Income 429M 787M 921M 754M 708M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 141M 156M 185M 218M 210M
Research & Development - - - - -
Other SG&A 141M 156M 185M 218M 210M
Other Operating Expense 8M 10M 0 15M 70M
Unusual Expense 1.09B 117M 0 1.51B 166M
EBIT after Unusual Expense (1.09B) (117M) 0 (1.51B) (166M)
Non Operating Income/Expense 5M 423M 197M 136M 60M
Non-Operating Interest Income 0 0 0 0 0
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense 76M 98M 93M 137M 152M
Gross Interest Expense 127M 156M 175M 205M 205M
Interest Capitalized 51M 58M 82M 68M 53M
Pretax Income (885M) 829M 840M (988M) 170M
Income Tax (343M) 306M 301M 196M 62M
Income Tax - Current Domestic 4M (1M) 17M 2M (4M)
Income Tax - Current Foreign 44M 60M 76M 193M -
Income Tax - Deferred Domestic (380M) 244M 201M 8M 66M
Income Tax - Deferred Foreign (11M) 3M 7M (7M) -
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 (20M)
Consolidated Net Income (542M) 523M 539M (1.18B) 88M
Minority Interest Expense 0 0 0 0 0
Net Income (542M) 523M 539M (1.18B) 88M
Extraordinaries & Discontinued Operations 0 0 0 0 39M
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 39M
Net Income After Extraordinaries (542M) 523M 539M (1.18B) 127M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (542M) 523M 539M (1.18B) 88M
EPS (Basic) (4.18) 3.97 4.03 (8.80) 0.94
Basic Shares Outstanding 130M 132M 134M 135M 135M
EPS (Diluted) (4.18) 3.91 3.99 (8.80) 0.94
Diluted Shares Outstanding 130M 134M 135M 135M 136M
EBITDA 867M 1.27B 1.5B 1.48B 1.36B
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Finzly's Strategic Move to Boost Innovation Alright, folks, it seems Finzly means business. They just roped in Paul Finch, the brains who gave us Zelle during his stint as CEO over at Early Warning Services. This guy's been around the block with a couple of the biggest names in banking, and if his past headlines are any indicator, he's got the knack for shaking things up...
Continue Reading
Sovereignty has become the corporate cloud world's favorite hard-edged word. Concierto is taking that word straight onto the Microsoft Ignite 2026 floor, and frankly, it is a sensible place to make the case. The company, part of Trianz, will appear as a Gamechanger Sponsor from November 17 through 20 at San Francisco's Moscone Center, showing its platform at Booth #5435....
Continue Reading
A lifetime of observation finally gets its own page Forty is an unusual age to begin writing poetry, which is exactly why Joyce Ann Grooms McGeehan's debut has a little more texture than the usual polished promise of inspiration. Thoughts Unleashed by an Independent, American Woman comes from someone who spent decades teaching French, English, and ESL, then retired to a...
Continue Reading
Red Cat's Revenue Predictions Crash and Burn Sitting there on August 6, 2026, Red Cat Holdings had everyone believing they were on a fast track to hitting a hefty revenue target: $150–$180 million for FY2026. CEO Jeffrey Thompson didn't mince words, boasting confidence like a captain before a storm. Fast forward three months, and they're waving the white flag, tossing...
Continue Reading
Ten billion parcels can hide plenty of ugly economics, but ZTO's third quarter does not look like a volume-at-any-cost stunt. The company moved 10.241 billion parcels, up 7.0% from a year earlier, and says that outpaced the industry by 4.1 percentage points. More importantly, revenue climbed 21.0% to RMB14.36 billion while adjusted net income reached RMB2.57 billion. That...
Continue Reading
Cashing In to Conquer Cancer In the risk-laden world of biotech, Onward Therapeutics has just bagged a hefty NT$900 million—roughly US$28 million—from its Series B financing. That's not pocket change and speaks to the level of confidence their backers have, even as they plant their global headquarters firmly in Taipei since relocating from Switzerland. A Deep Dive...
Continue Reading
Telarus just pulled another serious capital partner into the room, and that matters more than the usual law-firm victory lap. Snowhawk Partners has invested in the technology services distributor alongside Columbia Capital, which remains a long-standing partner. Nobody disclosed a valuation, ownership percentage, financing mix, or closing date. Annoying? Sure. But the...
Continue Reading
The Red Kiosk Revolution It's not every day that a church initiative pops up in global conversations, but here we are—ten years into the Light the World initiative by The Church of Jesus Christ of Latter-day Saints. What's interesting is how these little kiosks, like silent ambassadors, have become a staple in 145 spots this holiday season, spanning continents. Each...
Continue Reading
A tuition award can still leave a brutal hole in the budget. That is the plain fact sitting underneath Caracal Products & Services’ $200,000 commitment to Virginia Military Institute. Federal ROTC scholarships can cover tuition, but VMI says room, board and quartermaster fees average about $15,000 annually. For a student who has done everything right—earned the ROTC...
Continue Reading
New Frontiers: Adrenyx Biosciences Takes Shape Well, here's a new chapter in biotech drama. Spruce Biosciences, a name you might have tangled with if you're into tickers like NASDAQ:SPRB, just carved out a niche with the birth of Adrenyx Biosciences. The play? A separate company eyeing the endocrinology space, setting its sights on tackling congenital adrenal hyperplasia...
Continue Reading
Top 5 Most Recently Viewed Articles
Key Deadline for Metagenomi Investors As investors in Metagenomi, Inc. keep a close watch, an important deadline is approaching. The time to file a lead plaintiff motion in the class action lawsuit is set for November 25, 2024. This action is vital for those who purchased or acquired Metagenomi securities, specifically those linked to the company’s latest initial public...
Continue Reading
Structure Therapeutics Engages with Investors at Key Conferences Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company, is gearing up to participate in important investor conferences this September. The company is dedicated to developing innovative oral small molecule therapeutics aimed at treating metabolic and cardiopulmonary...
Continue Reading
OmaSp's Strong Financial Performance and Future Outlook OMA SAVINGS BANK PLC has recently released its financial statements for the year ending December 31, 2024, showing promising results and projections for continued growth. Known as OmaSp, the bank reported a noteworthy fourth quarter, aligning with the expectations set forth at the beginning of the year, and a solid...
Continue Reading
Reagan National Economic Forum Set to Inspire Economic Solutions The Ronald Reagan Presidential Foundation and Institute is gearing up for a transformative inaugural economic summit with leading figures from the business and economic policy landscapes to take place in late May 2025. About the Forum’s Objectives The Reagan National Economic Forum (RNEF) aims to provide a...
Continue Reading
Celebrating the Latino Business Community Prepare yourself for an unforgettable networking event dedicated to the Latino business community, brought to you by Latin Biz Today and Mercy University. The Spectrum of Success event promises a night filled with excitement, learning, and cultural experiences that will leave a lasting impression on everyone involved. A Night of...
Continue Reading